|
MTMR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.043600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.124200E-01 |
| Normal-vs-Stage2 |
4.678200E-01 |
| Normal-vs-Stage3 |
7.224200E-01 |
| Normal-vs-Stage4 |
2.758000E-01 |
| Stage1-vs-Stage2 |
6.913600E-01 |
| Stage1-vs-Stage3 |
3.537400E-01 |
| Stage1-vs-Stage4 |
8.388400E-02 |
| Stage2-vs-Stage3 |
3.416200E-01 |
| Stage2-vs-Stage4 |
1.624760E-01 |
| Stage3-vs-Stage4 |
5.262000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.315400E-01 |
| Normal-vs-AfricanAmerican |
1.88727999999028E-05 |
| Normal-vs-Asian |
9.230400E-01 |
| Caucasian-vs-AfricanAmerican |
2.03650000196731E-08 |
| Caucasian-vs-Asian |
8.983600E-01 |
| AfricanAmerican-vs-Asian |
3.796000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.402800E-01 |
| Normal-vs-Female |
5.236800E-01 |
| Male-vs-Female |
3.567400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.789800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.395000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.859000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.421200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.147400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.736000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.503800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.218400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.005600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.487600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.384800E-01 |
| Normal-vs-Grade 2 |
1.466590E-01 |
| Normal-vs-Grade 3 |
6.240600E-01 |
| Normal-vs-Grade 4 |
2.504800E-01 |
| Grade 1-vs-Grade 2 |
9.988800E-01 |
| Grade 1-vs-Grade 3 |
4.056400E-01 |
| Grade 1-vs-Grade 4 |
1.615980E-01 |
| Grade 2-vs-Grade 3 |
3.052100E-02 |
| Grade 2-vs-Grade 4 |
3.851500E-02 |
| Grade 3-vs-Grade 4 |
3.669600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.777940E-03 |
| Normal-vs-ccB subtype |
3.260600E-01 |
| ccA subtype-vs-ccB subtype |
5.99359999999827E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.990200E-01 |
| Normal-vs-N1 |
8.270300E-02 |
| N0-vs-N1 |
1.126780E-01 |
|
|
